[ET Net News Agency, 11 June 2021] SIMCERE PHARMA (02096) rose 3.36% to HK$12.92.
It hits an intra-day high of HK$12.92, hitting a historical high, and an intra-day low
of HK$12.34. The total shares traded was 611,000, with a value of HK$7.77m. The active
buy/sell ratio is 80:20, with net buying turnover of HK$4.55m. DAIWA CAPITAL MARKETS HK
accounts for greatest net responsive buying turnover of HK$334,435, with volume weighted
average price of HK$12.652. CHINA INV INFO accounts for greatest net responsive selling
turnover of HK$944,807, with volume weighted average price of HK$12.71. The stock has
risen a combined 21.43% over the past 5 consecutive trading days.
The Hang Seng Index now rose 64 points, or 0.22% to 28,803; the Hang Seng China
Enterprises Index now rose 8 points, or 0.08% to 10,724; the Hang Seng TECH Index now rose
18 points, or 0.23% to 7,987; with an overall turnover of HK$40.51b.
The SSE Composite Index now fell 11 points, or 0.33% to 3,599, with an overall turnover
of RMB188.22b.
The SZSE Component Index now fell 97 points, or 0.66% to 14,795, with an overall
turnover of RMB126.37b.
Basic Information
-------------------------------------------
Nominal 12.920 % Chg +3.36%
High 12.920 Low 12.340
Shares Tr 611,000 Turnover 7.77m
10-D SMA 11.520 %H.V 70.277
20-D SMA 10.140 VWAP 12.721
50-D SMA 8.948 RSI14 82.111
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 80:20, with net buying
turnover of HK$4.55m, rising a combined 21.43% over the past 5 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SIMCERE PHARMA (02096) 12.92 +3.36
SIHUAN PHARM (00460) 3.37 -0.88
TRAD CHI MED (00570) 5.03 -0.20
CMS (00867) 21.70 -3.56
CSPC PHARMA (01093) 12.28 +0.33
SINO BIOPHARM (01177) 8.37 -1.18
3SBIO (01530) 10.48 +3.97
LUYE PHARMA (02186) 5.63 +2.92
FOSUN PHARMA (02196) 60.40 -0.08
PHARMARON (03759) 190.20 +4.22
-------------------------------------------------
(ed)